Filtros de búsqueda

Lista de obras de

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

article

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers

artículo científico publicado en 2014

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

artículo científico publicado en 2011

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

artículo científico publicado en 2010

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

A novel clinical trial recruitment strategy for women's cancer

artículo científico publicado en 2015

A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission.

artículo científico

A scalable filtration method for high throughput screening based on cell deformability

artículo científico publicado en 2019

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

artículo científico publicado en 2014

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

scientific article published on August 2013

Activation of the MEK-S6 pathway in high-grade ovarian cancers

artículo científico publicado en 2010

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

artículo científico

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

artículo científico publicado en 2018

Adverse health outcomes in women exposed in utero to diethylstilbestrol

artículo científico publicado en 2011

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

article

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

article

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation

scientific article published on 21 May 2018

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2016

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

artículo científico publicado en 2017

Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition

artículo científico publicado en 2020

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

artículo científico publicado en 2013

Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers

article

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

artículo científico publicado en 2015

Assessment of hepatocyte growth factor in ovarian cancer mortality

artículo científico publicado en 2011

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

artículo científico publicado en 2016

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

artículo científico publicado en 2012

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2018

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma ⬇️

artículo científico publicado el 31 de agosto de 2010

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

artículo científico publicado en 2015

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Biopsychological stress factors in BRCA mutation carriers

artículo científico publicado en 2012

Breast cancer following ovarian cancer in BRCA mutation carriers

artículo científico publicado en 2014

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation

scientific article published on 30 September 2020

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

artículo científico publicado en 2015

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

scientific article published on 18 June 2020

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2008

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

artículo científico publicado en 2014

Coexisting ovarian malignancy in young women with endometrial cancer

artículo científico publicado en 2005

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

artículo científico publicado en 2015

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at 19p13 are associated with susceptibility to ovarian cancer

artículo científico publicado en 2010

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

artículo científico publicado en 2015

Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection

artículo científico publicado en 2010

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

artículo científico publicado en 2008

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

artículo científico publicado en 2014

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

artículo científico publicado en 2023

Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection

artículo científico publicado en 2010

Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

artículo científico publicado en 2020

Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo

artículo científico publicado en 2008

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis

artículo científico publicado en 2015

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer

artículo científico publicado en 2010

Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?

artículo científico publicado en 2020

Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?

artículo científico publicado en 2015

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

artículo científico publicado en 2017

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

artículo científico publicado en 2013

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

scholarly article published in Nature Genetics

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

artículo científico publicado en 2014

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

artículo científico publicado en 2015

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk

artículo científico publicado en 2016

Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis

artículo científico publicado en 2011

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer

artículo científico publicado en 2014

Factors associated with high-cost hospitalizations in elderly ovarian cancer patients

artículo científico publicado en 2020

Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

artículo científico publicado en 2020

Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation

article

Functional domains of CCN1 (Cyr61) regulate breast cancer progression.

artículo científico publicado en 2008

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

artículo científico publicado en 2013

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

artículo científico publicado en 2010

Generating longitudinal screening algorithms using novel biomarkers for disease.

artículo científico publicado en 2002

Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

artículo científico publicado en 2018

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

artículo científico publicado en 2012

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

artículo científico publicado en 2015

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

article

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

scientific article published on 18 May 2020

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

artículo científico publicado en 2013

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

artículo científico publicado en 2015

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

artículo científico publicado en 2014

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

artículo científico publicado en 2016

Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene

artículo científico publicado en 2017

Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.

artículo científico publicado en 2017

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

artículo científico publicado en 2019

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

artículo científico publicado en 2017

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

artículo científico publicado en 2017

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report

artículo científico publicado en 2017

Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers

artículo científico publicado en 2018

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study

artículo científico publicado en 2016

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2005

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

artículo científico publicado en 2013

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

artículo científico publicado en 2016

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.

artículo científico publicado en 2013

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

artículo científico publicado en 2014

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

artículo científico publicado en 2016

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

scientific article published on 11 April 2019

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

artículo científico publicado en 2016

Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK.

artículo científico publicado en 2011

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

artículo científico publicado en 2014

Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein

artículo científico publicado en 2009

Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500

article

Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2020

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling

artículo científico publicado en 2003

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening

artículo científico publicado en 2010

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2016

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

scientific article published on 19 June 2019

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

artículo científico publicado en 2018

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

artículo científico publicado en 2018

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

artículo científico publicado en 2015

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

artículo científico publicado en 2016

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2019

Ovarian cancer screening

artículo científico publicado en 2003

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations

artículo científico publicado en 2016

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2011

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility

artículo científico publicado en 2002

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer

artículo científico publicado en 2005

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

artículo científico publicado en 2010

Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients

artículo científico publicado en 2011

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

artículo científico publicado en 2020

Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium

artículo científico publicado en 2011

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer

artículo científico publicado en 2020

Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium

artículo científico publicado en 2017

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube

artículo científico publicado en 2010

Profiling the perpetrator

artículo científico publicado en 2004

Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2018

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Rapid progression of prostate cancer in men with a BRCA2 mutation

artículo científico publicado en 2008

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition

artículo científico publicado en 2010

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).

artículo científico publicado en 2003

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

article

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

artículo científico publicado en 2015

Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation

artículo científico publicado en 2010

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study

artículo científico publicado en 2015

Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?

artículo científico publicado en 2017

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

artículo científico publicado en 2013

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

artículo científico publicado en 2006

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

artículo científico publicado en 2011

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

artículo científico publicado en 2006

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

artículo científico publicado en 2016

The CYP1A2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA1 Mutation Carriers

scientific article published on 01 May 2007

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

scientific article published on 01 November 2019

The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2018

The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer

artículo científico publicado en 2005

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study

artículo científico publicado en 2013

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing

artículo científico publicado en 2011

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

artículo científico publicado en 2014

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

artículo científico publicado en 2020

Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation

artículo científico publicado en 2015

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

artículo científico publicado en 2005

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

artículo científico publicado en 2014

Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women

artículo científico publicado en 2014

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

artículo científico publicado en 2018

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

artículo científico publicado en 2014

Xeroderma pigmentosum complementation group C single‐nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression‐free survival in advanced ovarian cancer ⬇️

artículo científico publicado el 12 de julio de 2011

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2023

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda